Bianca Weinstock-Guttman

Upon completing her formal education, Weinstock-Guttman accepted a faculty position at University of Buffalo in 1998.^[2] In 2006, she helped establish the Pediatric MS Center of Buffalo with a grant from the National Multiple Sclerosis Society.^[2] In this role, she received the 2013 UB Exceptional Scholars Sustained Achievement Award.^[3]

In 2017, Weinstock-Guttman was named the principal investigator to lead clinical trials exploring potential therapeutic applications of cannabinoids in progressive multiple sclerosis.^[4] The following year, she received the National Multiple Sclerosis Society's Impact Award for her research, patient care and advocacy skills.^[5] During the COVID-19 pandemic, Weinstock-Guttman co-authored Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient with Dejan Jakimovski.^[6] She was also the recipient of the 2020 Stockton Kimball Award for outstanding scientific achievement and service.^[7] The following year, she was promoted to the rank of SUNY Distinguished Professor, the highest rank in the SUNY system.^[8]

• Bianca Weinstock-Guttman publications indexed by Google Scholar